Growth Metrics

Cellectis (CLLS) Amortization (2016 - 2022)

Historic Amortization for Cellectis (CLLS) over the last 7 years, with Q3 2022 value amounting to $45.6 billion.

  • Cellectis' Amortization rose 32537007.14% to $45.6 billion in Q3 2022 from the same period last year, while for Sep 2022 it was $136.6 billion, marking a year-over-year increase of 20034.19%. This contributed to the annual value of $39.1 billion for FY2016, which is 130393169052.63% up from last year.
  • Per Cellectis' latest filing, its Amortization stood at $45.6 billion for Q3 2022, which was up 32537007.14% from $45.5 billion recorded in Q2 2022.
  • Cellectis' Amortization's 5-year high stood at $45.6 billion during Q3 2022, with a 5-year trough of $14.0 million in Q3 2021.
  • Its 5-year average for Amortization is $23.8 billion, with a median of $36.1 billion in 2018.
  • As far as peak fluctuations go, Cellectis' Amortization plummeted by 9975.38% in 2019, and later soared by 32537007.14% in 2022.
  • Cellectis' Amortization (Quarter) stood at $23.1 million in 2018, then plummeted by 32.34% to $15.6 million in 2019, then surged by 31.18% to $20.5 million in 2020, then plummeted by 31.59% to $14.0 million in 2021, then skyrocketed by 325370.07% to $45.6 billion in 2022.
  • Its Amortization was $45.6 billion in Q3 2022, compared to $45.5 billion in Q2 2022 and $45.5 billion in Q1 2022.